Gene expression profiling does not predict long-term risk of malignancy in heart transplant recipients

Key Points

• Long-term risk of malignancy was not predicted by gene expression profiling in heart transplant recipients, indicating potential limitations in existing assessments.
• The study analyzed data from multiple heart transplant recipients over a significant follow-up period to assess malignancy risk against gene expression changes.
• Gene expression profiling was utilized as a method to evaluate long-term health outcomes, but results reveal no predictive value for malignancy risk in the cohort.
• This analysis emphasizes the need for alternative biomarkers or methods to effectively assess malignancy risk, given the limitations of gene expression profiling.